These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 11875284)
61. Epidemiology of Treatment for Preschoolers on Kentucky Medicaid Diagnosed with Attention-Deficit/Hyperactivity Disorder. Davis DW; Feygin Y; Creel L; Kong M; Jawad K; Sun J; Blum NJ; Lohr WD; Williams PG; Le J; Jones VF; Pasquenza N J Child Adolesc Psychopharmacol; 2020 Sep; 30(7):448-455. PubMed ID: 32614247 [No Abstract] [Full Text] [Related]
62. Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects. Hart H; Radua J; Nakao T; Mataix-Cols D; Rubia K JAMA Psychiatry; 2013 Feb; 70(2):185-98. PubMed ID: 23247506 [TBL] [Abstract][Full Text] [Related]
63. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ. Aman MG; Binder C; Turgay A J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021 [TBL] [Abstract][Full Text] [Related]
64. Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a county-wide sample. Wolraich ML; Hannah JN; Baumgaertel A; Feurer ID J Dev Behav Pediatr; 1998 Jun; 19(3):162-8. PubMed ID: 9648041 [TBL] [Abstract][Full Text] [Related]
65. Risk of Irritability With Psychostimulant Treatment in Children With ADHD: A Meta-Analysis. Stuckelman ZD; Mulqueen JM; Ferracioli-Oda E; Cohen SC; Coughlin CG; Leckman JF; Bloch MH J Clin Psychiatry; 2017 Jun; 78(6):e648-e655. PubMed ID: 28682529 [TBL] [Abstract][Full Text] [Related]
66. Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD. Lachaine J; Sikirica V; Mathurin K BMC Psychiatry; 2016 Jan; 16():11. PubMed ID: 26774811 [TBL] [Abstract][Full Text] [Related]
67. Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders. Pringsheim T; Steeves T Cochrane Database Syst Rev; 2011 Apr; (4):CD007990. PubMed ID: 21491404 [TBL] [Abstract][Full Text] [Related]
68. Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(34):842-7. PubMed ID: 16138075 [TBL] [Abstract][Full Text] [Related]
70. Attention-deficit-hyperactivity disorder: an update. Dopheide JA; Pliszka SR Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419 [TBL] [Abstract][Full Text] [Related]
71. Stimulant treatment and injury among children with attention deficit hyperactivity disorder: an application of the self-controlled case series study design. Raman SR; Marshall SW; Haynes K; Gaynes BN; Naftel AJ; Stürmer T Inj Prev; 2013 Jun; 19(3):164-70. PubMed ID: 23143347 [TBL] [Abstract][Full Text] [Related]
72. Attention deficit hyperactivity disorder in sport: a review. Corrigan B Int J Sports Med; 2003 Oct; 24(7):535-40. PubMed ID: 12968213 [TBL] [Abstract][Full Text] [Related]
73. The dopamine transporter and attention-deficit/hyperactivity disorder. Madras BK; Miller GM; Fischman AJ Biol Psychiatry; 2005 Jun; 57(11):1397-409. PubMed ID: 15950014 [TBL] [Abstract][Full Text] [Related]
74. Cocaine or Methamphetamine Use During Young Adulthood Following Stimulant Use for Attention-Deficit/Hyperactivity Disorder During Adolescence. McCabe SE; Schulenberg JE; Wilens TE; Schepis TS; McCabe VV; Veliz PT JAMA Netw Open; 2023 Jul; 6(7):e2322650. PubMed ID: 37432689 [TBL] [Abstract][Full Text] [Related]
75. Impact of Central Nervous System Stimulant Medication Use on Growth in Pediatric Populations with Attention-Deficit/Hyperactivity Disorder: A Review. Troksa K; Kovacich N; Moro M; Chavez B Pharmacotherapy; 2019 Jun; 39(6):665-676. PubMed ID: 30368860 [TBL] [Abstract][Full Text] [Related]
76. Response and Side Effects Using Stimulant Medication in Older Adults With ADHD: An Observational Archive Study. Michielsen M; Kleef D; Bijlenga D; Zwennes C; Dijkhuizen K; Smulders J; Hazewinkel A; Beekman ATF; Kooij JJS J Atten Disord; 2021 Oct; 25(12):1712-1719. PubMed ID: 32508213 [No Abstract] [Full Text] [Related]
77. Prevalence, incidence, and stimulant use of attention-deficit hyperactivity disorder in Taiwan, 1996-2005: a national population-based study. Chien IC; Lin CH; Chou YJ; Chou P Soc Psychiatry Psychiatr Epidemiol; 2012 Dec; 47(12):1885-90. PubMed ID: 22476209 [TBL] [Abstract][Full Text] [Related]
78. Prevalence and Predictors of Medication Use in Children with Attention-Deficit/Hyperactivity Disorder: Evidence from a Community-Based Longitudinal Study. Efron D; Gulenc A; Sciberras E; Ukoumunne OC; Hazell P; Anderson V; Silk TJ; Nicholson JM J Child Adolesc Psychopharmacol; 2019 Feb; 29(1):50-57. PubMed ID: 30508385 [TBL] [Abstract][Full Text] [Related]